NeuroTronik

NeuroTronik is producer of medical devices for treatment of an acute heart failure. The company is founded in 2012 and is based in the city of Chapel-Hill (the State of North Carolina, the USA).

2017: Investments of Boston Scientific

In April, 2017 NeuroTronik announced the investment attraction in the amount of $23.1 million. The new round of financing of the company headed the American producer of the medical equipment Boston Scientific.

Besides, NeuroTronik got a financial support from several investment funds among which — Hatteras Venture Partners, Synergy Life Science Partners, Lord Baltimore Investment Partners, Mountain Group Capital and Sovereign’s Capital.

Office Boston Scientific

NeuroTronik attracted investments to bring the NeuroTronik CANS Therapy system to the European market. This device is used to stimulation of fibers of autonomous nervous system through a special tube of NeuroCatheter which is located in a vein slightly above heart. Increase in warm emission without increase in heart rate is result of stimulation.

Our command achieved significant progress in development of NeuroTronik CANS Therapy — the technical director and the senior vice president for NeuroTronik research and development Steve Masson says, commenting on attraction of financing from investors. — At the moment the results of our clinical work which are very encouraging as we achieved security, efficiency and ease of use of a system. Now [having received money from investors — comments of TAdviser] we are ready to the following steps in our clinical trial.

The CEO of NeuroTronik Fred McCoy noted that NeuroTronik CANS Therapy in the long term can become the unique and valuable tool for doctors.^[1]

Notes